Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma (Q33809420)

29 July 2017

1 reference

title

Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma (English)

1 reference

hepatitis C virus related hepatocellular carcinoma

29 July 2017

1 reference

1 reference

Colombo M

1

1 reference

29 July 2017

1 January 1999

1 reference

29 July 2017

Journal of Hepatology

1 reference

29 July 2017

31 Suppl 1

1 reference

29 July 2017

25-30

1 reference

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus antibody and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Liver cancer in Thailand. II. A case-control study of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Detection of hepatitis C virus RNA in sera and liver tissues of non-A, non-B hepatitis patients using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Minus strand RNA of hepatitis C virus liver tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Detection of hepatitis C virus RNA in hepatocellular carcinoma by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

HCV-associated liver cancer without cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Influence of hepatitis b virus infection and age on mode of growth of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Workshop on Screening for Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Suppression of apoptotic cell death by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Transcriptional repression of p53 promoter by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Transgenic expression of hepatitis C virus structural proteins in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

Hepatitis C virus core and E2 protein expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980370-5

7 January 2021

10.1016/S0168-8278(99)80370-5

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10622556